In our study, patients with PTC tumors over 1 cm harboring BRAF V600E mutation had higher rates of lymph node metastasis, multifocality, and extra-thyroid extension. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.